Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design

Overview of attention for article published in Leukemia & Lymphoma, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,379 followers.

Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design #lymphoma #lymsm https://t.co/sH7UZC1RL7

New article: Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design https://t.co/Dfm7b8UsoZ #MCL #lymsm #hematology https://t.co/ypqOqIZQbe

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.